DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,044 | +12.8% | 19,705 | -1.4% | 0.00% | 0.0% |
| Q2 2023 | $258,115 | +52.0% | 19,978 | +15.4% | 0.00% | 0.0% |
| Q1 2023 | $169,772 | -15.3% | 17,306 | -8.1% | 0.00% | 0.0% |
| Q4 2022 | $200,458 | +17.9% | 18,840 | +15.9% | 0.00% | 0.0% |
| Q3 2022 | $170,000 | -19.0% | 16,249 | -2.5% | 0.00% | 0.0% |
| Q2 2022 | $210,000 | -4.1% | 16,664 | -17.6% | 0.00% | – |
| Q1 2022 | $219,000 | -34.0% | 20,215 | -14.2% | 0.00% | -100.0% |
| Q4 2021 | $332,000 | +25.3% | 23,556 | +70.6% | 0.00% | 0.0% |
| Q3 2021 | $265,000 | -3.6% | 13,809 | -50.6% | 0.00% | 0.0% |
| Q2 2021 | $275,000 | -1.4% | 27,969 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $279,000 | +165.7% | 28,366 | +20.5% | 0.00% | – |
| Q4 2020 | $105,000 | +87.5% | 23,538 | +80.8% | 0.00% | – |
| Q3 2020 | $56,000 | -48.1% | 13,022 | +7.1% | 0.00% | -100.0% |
| Q2 2020 | $108,000 | +66.2% | 12,155 | +7.6% | 0.00% | – |
| Q4 2019 | $65,000 | – | 11,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |